Disease | pneumonia |
Phenotype | C0019829|hodgkin lymphoma |
Sentences | 7 |
PubMedID- 25715489 | [pneumocystis pneumonia in patients with hodgkin lymphoma]. |
PubMedID- 23053189 | R-chop chemotherapy composed of rituximab, cyclophosphamide, adriamycin, vincristine, and prednisolone which might increase the risk of pneumocystis pneumonia in patients with non-hodgkin lymphoma. |
PubMedID- 25356925 | Incidence of pneumonitis in patients with non-hodgkin lymphoma receiving chemoimmunotherapy with rituximab. |
PubMedID- 22019238 | Predictive factors for radiation pneumonitis in hodgkin lymphoma patients receiving combined-modality therapy. |
PubMedID- 21849075 | Legionella pneumophila serogroup 3 pneumonia in a patient with low-grade 4 non-hodgkin lymphoma: a case report. |
PubMedID- 25863764 | Purpose: few studies to date have evaluated factors associated with the development of radiation pneumonitis (rp) in patients with hodgkin lymphoma (hl) and non-hodgkin lymphoma (nhl), especially in patients treated with contemporary radiation techniques. |
PubMedID- 20919860 | An increasing incidence of pneumocystis jiroveci pneumonia (pcp) in patients with b-cell non-hodgkin lymphoma (b-nhl) receiving rituximab treatment has been reported. |
Page: 1